Patent details

Basic Information

Publication number:

EP1684719

WO Application Number:

Type:

European Patent Granted for NL

Status:

Lapsed by non-payment of annual fee Art. 62 ROW

Publication Title:

Title When Made Available For Viewing:

Reason Lapsed:

Application number:

EP04811377.3

WO Publication Number:

EPO Publication Language:

English

SPC Number:

First Applicant Residence Country:

United States of America (US)

Publications:

Dates

Filing date:

11/11/2004

Grant date:

26/10/2011

EP Publication Date:

26/10/2011

WO Publication Date:

Claims Translations Received Date:

Claims Translation B1 Received Date:

Claims Translation B2 Received Date:

Claims Translation B3 Received Date:

Lapsed By Non Payment Annual Fee Date:

01/12/2019

Renunciation Date:

NullificationDate:

Published:

Due To Cession Date:

Registration date:

26/10/2011

EP B1 Publication Date:

26/10/2011

EP B2 Publication Date:

EP B3 Publication Date:

Description Translation B1 Received Date:

10/01/2012

Description Translation B2 Received Date:

Description Translation B3 Received Date:

Expiration date:

10/11/2024

Lapsed By Expiration Date:

Revocation Date:

Invalidity Date:

Response To Novelty Search Report Received:

Patent Granting Request:

Lapsed date:

Applicant/holder

From:

29/06/2017

 

 

 

Name:

Baxalta Incorporated

Address:

1200 Lakeside Drive, 60015, Bannockburn, Illinois, United States of America (US)

From:

29/06/2017

 

 

 

Name:

Baxalta GmbH

Address:

Thurgauerstrasse 130, 8152, Glattpark, (Opfikon), Switzerland (CH)

From:

29/06/2017

 

 

 

Name:

Arriva Pharmaceuticals, Inc.

Address:

2020 Challenger Drive, ALAMEDA, CA 94501, United States of America (US)

Historical Applicant/holder

From:

26/10/2011

To:

29/06/2017

 

Name:

Baxter International Inc.

Address:

One Baxter Parkway, DEERFIELD, IL 60015, United States of America (US)

From:

26/10/2011

To:

29/06/2017

 

Name:

Baxter Healthcare SA

Address:

Hertistrasse 2, Wallisellen, 8304 ZURICH, Switzerland (CH)

From:

26/10/2011

To:

29/06/2017

 

Name:

Arriva Pharmaceuticals, Inc.

Address:

2020 Challenger Drive, ALAMEDA, CA 94501, United States of America (US)

Inventor

1

Name:

DURRANI, Manzer J.

Address:

PLANTATION, FL 33322, United States of America (US)

2

Name:

KUMAR, Harish

Address:

FULLERTON, CA 92833, United States of America (US)

3

Name:

KREIGER, Timothy

Address:

LOWELL, MA 01854, United States of America (US)

4

Name:

KABINGUE, Ken

Address:

LOS ANGELES, CA 90041, United States of America (US)

5

Name:

MOSHER, Virginia

Address:

LEBANON, MO 65536, United States of America (US)

6

Name:

BARR, Philip J.

Address:

OAKLAND, CA 94619, United States of America (US)

7

Name:

BATHURST, Ian C.

Address:

ALAMEDA, CA 94501, United States of America (US)

Priority

Priority Patent Number:

520549 P

Priority Date:

14/11/2003

Priority Country:

United States of America (US)

Classification

Main IPC Class:

A61K 9/12;

IPC or IDT classification:

A61P 11/00;

Publication

Bulletin

1

Bulletin Heading:

VRV

Journal edition number:

28/20

Publication date:

08/07/2020

Description:

Lapse or annulment

2

Bulletin Heading:

CO

Journal edition number:

41/17

Publication date:

11/10/2017

Description:

Changes in the Netherlands Patent Register

3

Bulletin Heading:

EP3

Journal edition number:

2012/04

Publication date:

25/01/2012

Description:

European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:

EP2

Journal edition number:

2011/44

Publication date:

02/11/2011

Description:

European patents granted for the Netherlands

European Patent Bulletin

Issue number:

201143

Publication date:

26/10/2011

Description:

Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Assignment

Deed Number:

RC201701624B

Date Registered:

29/06/2017

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

Baker & McKenzie Amsterdam N.V.

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Added Owner(s)

1

Name:

Arriva Pharmaceuticals, Inc.

Address:

2020 Challenger Drive, ALAMEDA, CA 94501, United States of America (US)

2

Name:

Baxalta Incorporated

Address:

Zaehlerweg 4, 6300, Zug, United States of America (US)

3

Name:

Baxalta GmbH

Address:

Thurgauerstrasse 130, 8152, Glattpark, (Opfikon), Switzerland (CH)

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Annual Fee

Annual Fee(s) Due Date:

Annual Fee Number:

Last Annual Payment Date:

26/10/2018

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

900 Euro

Payer:

Anaqua Services

	Filing date	Document type	Document Description	Number of pages	File Type
	10/10/2017	Outgoing Correspondence	Letter registration deed	2	PDF	/7/7/3/1/1/0504811377/docs/ep04811377.3_1_166845l118.pdf
	29/06/2017	Request for Change	First filed deed	178	PDF	/7/7/3/1/1/0504811377/docs/ep04811377.3_0_rfc20170921030820492.pdf
	10/01/2012	Outgoing Correspondence	Outgoing Letter	1	PDF	/7/7/3/1/1/0504811377/docs/ep04811377.3_2_outgoingcorrespondence20120110.pdf
	10/01/2012	Incoming Correspondence Paper	Accompanying letter incoming document	2	PDF	/7/7/3/1/1/0504811377/docs/ep04811377.3_3_incomingcorrespondencepaper20120110.pdf
	10/01/2012	Claims	Translated claims	4	PDF	/7/7/3/1/1/0504811377/docs/ep04811377.3_4_claims20120110.pdf